文献速递乳腺癌放疗放疗物理与技术

乳腺癌放疗中三维适形与调强放疗的疗效比较

Comparative Effectiveness Analysis of 3D-Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy (IMRT) in a Prospective Multicenter Cohort of Patients With Breast Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-10-08

该前瞻性多中心队列研究比较了乳腺癌辅助全乳放疗中3DCRT与IMRT的急性毒性。结果显示,逆向计划IMRT较3DCRT显著降低急性毒性,常规分割下OR为0.64(95%CI 0.45-0.91),大分割下OR为0.41(95%CI 0.26-0.65)。

要点

  • 逆向计划IMRT较3DCRT显著降低急性毒性,常规分割OR 0.64(95%CI 0.45-0.91)。
  • 大分割放疗中逆向计划IMRT的急性毒性OR为0.41(95%CI 0.26-0.65)。
  • 前瞻性设计分常规分割与大分割亚组,各技术组急性毒性发生率均有报告。

核心结论

  • 逆向计划IMRT较3DCRT显著降低乳腺癌辅助全乳放疗的急性毒性。

研究设计与样本

  • 前瞻性多中心队列研究,纳入2011至2018年23家机构接受辅助全乳放疗(无淋巴结照射)的患者。
  • 比较3DCRT与IMRT(逆向计划或前向计划且每机架角≥5个子野)的急性毒性(中重度疼痛或湿性脱皮)。
  • 采用逆概率治疗加权多变量模型,并将治疗机构作为随机效应调整。

主要发现

  • 常规分割3DCRT组1185例中650例(54.9%)发生急性毒性,逆向计划IMRT组580例中245例(42.2%)。
  • 大分割3DCRT组1296例中432例(33.3%)发生急性毒性,逆向计划IMRT组623例中164例(26.3%)。
  • 多变量分析显示逆向计划IMRT vs 3DCRT的急性毒性OR:常规分割0.64(95%CI 0.45-0.91),大分割0.41(95%CI 0.26-0.65)。
  • 常规分割高度分段前向计划IMRT组774例中458例(59.2%)发生急性毒性;大分割高度分段前向计划IMRT组709例中227例(32.0%)发生急性毒性。

临床怎么用

  • 在乳腺癌辅助全乳放疗中,逆向计划IMRT可较3DCRT降低急性毒性,尤其在大分割方案中。
  • 选择技术时需结合分次方案考虑,逆向计划IMRT可能为降低急性皮肤毒性提供优势。

局限性

  • 研究未识别介导该关联的剂量学差异。
  • 需进一步评估成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Simple intensity modulation of radiation therapy reduces acute toxicity compared with 2-dimensional techniques in adjuvant breast cancer treatment, but it remains unknown whether more complex or inverse-planned intensity modulated radiation therapy (IMRT) offers an advantage over forward-planned, 3-dimensional conformal radiation therapy (3DCRT). METHODS AND MATERIALS: Using prospective data regarding patients receiving adjuvant whole breast radiation therapy without nodal irradiation at 23 institutions from 2011 to 2018, we compared the incidence of acute toxicity (moderate-severe pain or moist desquamation) in patients receiving 3DCRT versus IMRT (either inverse planned or, if forward-planned, using ≥5 segments per gantry angle). We evaluated associations between technique and toxicity using multivariable models with inverse-probability-of-treatment weighting, adjusting for treatment facility as a random effect. RESULTS: Of 1185 patients treated with 3DCRT and conventional fractionation, 650 (54.9%) experienced acute toxicity; of 774 treated with highly segmented forward-planned IMRT, 458 (59.2%) did; and of 580 treated with inverse-planned IMRT, 245 (42.2%) did. Of 1296 patients treated with hypofractionation and 3DCRT, 432 (33.3%) experienced acute toxicity; of 709 treated with highly segmented forward-planned IMRT, 227 (32.0%) did; and of 623 treated with inverse-planned IMRT, 164 (26.3%) did. On multivariable analysis with inverse-probability-of-treatment weighting, the odds ratio for acute toxicity after inverse-planned IMRT versus 3DCRT was 0.64 (95% confidence interval, 0.45-0.91) with conventional fractionation and 0.41 (95% confidence interval, 0.26-0.65) with hypofractionation. CONCLUSIONS: This large, prospective, multicenter comparative effectiveness study found a significant benefit from inverse-planned IMRT compared with 3DCRT in reducing acute toxicity of breast radiation therapy. Future research should identify the dosimetric differences that mediate this association and evaluate cost-effectiveness.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Jagsi R, Griffith KA, Moran JM, et al. Comparative Effectiveness Analysis of 3D-Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy (IMRT) in a Prospective Multicenter Cohort of Patients With Breast Cancer. Int J Radiat Oncol Biol Phys. 2021. PMID: 34634437. doi:10.1016/j.ijrobp.2021.09.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。